Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Eosinophil-guided Reduction of Inhaled Corticosteroids

NCT04481555 is registered in ClinicalTrials.gov with Chronic Obstructive Pulmonary Disease Trial Network, Denmark as lead sponsor.

NCT NCT04481555
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04481555 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Eosinophil-guided Reduction of Inhaled Corticosteroids
Lead sponsor
Chronic Obstructive Pulmonary Disease Trial Network, Denmark
Phase
Phase 4
Overall status
Completed
Start date
June 28, 2021
Completion date
November 19, 2025
Enrollment
444 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

azithromycin, copd, copd exacerbation, inhaled corticosteroid, pneumonia